Oxycodone Drugs Market Size and Share Analysis is Projected to Reach USD 8.29 Billion by 2032, to Grow at a CAGR of 5.4%

𝐎𝐱𝐲𝐜𝐨𝐝𝐨𝐧𝐞 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

With a compound annual growth rate (CAGR) of 5.4%, the global oxycodone drugs market is expected to reach a value of over USD 8.29 billion by 2032 from an estimated USD 5.19 billion in 2023.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market/request-for-sample

Oxycodone is utilized to alleviate pain grave enough to need an opioid cure and when alternate pain medicines do not function sufficiently and cannot be permitted. It is inherent in the collection of medicines known as narcotic analgesics. It treats the central nervous system to mitigate pain. Oxycodone expanded-release capsules or tablets should not be utilized if one requires pain medicine for an interim period, such as when recuperating from surgery. The medicine should not be utilized to mitigate tender pain or in situations when non-narcotic medication is productive.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬

• The oxycodone drugs market is expected to witness significant prospects due to factors such as the management of acute pain is feasible with the assistance of oxycodone drugs. Thus, they are altering the motif of prescription globally.
• These medications have acquired notable approval amongst healthcare experts due to their capacity to handle acute pain. This has restored the making to enhance the R&D and marketing prices for their oxycodone drugs.

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐒𝐧𝐚𝐩𝐬𝐡𝐨𝐭

Elements that impact the contesting in the market involve the standard of misuse dissuading several commodities as well their price, acceptability, and security profiles. Market leaders in the oxycodone drugs market are enumerated as follows:

• Acura Pharmaceuticals (U.S.)
• Alvogen (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Ascent Pharmaceuticals, Inc. (U.S.)
• Collegium Pharmaceutical (U.S.)
• Endo International plc (Ireland)
• Epic Pharma, LLC. (U.S.)
• Mallinckrodt (Ireland)
• Mundipharma International (UK)
• Pfizer Inc. (U.S.)
• Protega Pharmaceuticals Inc. (U.S.)
• Rhodes Pharmaceuticals L.P. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3295/2

𝐎𝐱𝐲𝐜𝐨𝐝𝐨𝐧𝐞 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.
• The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.
• Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.
• North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The regions covered in the report are Europe, North America, Asia Pacific, Middle East & Africa, and Latin America. Also, according to the study, in 2023, North America held the largest oxycodone drug market share. This is due to the growing approval of oxycodone medications as pain relief and the growing cases of detrimental illnesses. Moreover, the Asia Pacific region is anticipated to witness notable growth due to elements such as the escalated aggregate of surgical processes and the growing requirement for oxycodone for grave post-effective care.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐓𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐡𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market

𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐨𝐱𝐲𝐜𝐨𝐝𝐨𝐧𝐞 𝐝𝐫𝐮𝐠𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐝𝐫𝐮𝐠 𝐭𝐲𝐩𝐞, 𝐝𝐨𝐬𝐚𝐠𝐞 𝐟𝐨𝐫𝐦, 𝐚𝐧𝐝 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐧𝐞𝐥:

Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
• Short-acting
• Long-acting

Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)
• Tablet
• Capsule
• Injection

Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Rare Disease Diagnostics Market: https://www.polarismarketresearch.com/industry-analysis/rare-disease-diagnostics-market

Cancer Cachexia Market: https://www.polarismarketresearch.com/industry-analysis/cancer-cachexia-market

Oligonucleotide Synthesis Market: https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market

Cell Culture Market: https://www.polarismarketresearch.com/industry-analysis/cell-culture-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.